Biotechnology and genetics research have been the subject of extensive investment by both the public and private sectors, with the resulting products and processes making a significant and increasing contribution to human health and health care.
In this webinar recording, Anja Zimmerman, discusses how knowledge and technology transfer can happen in numerous ways, from publication of research results to collaborations between scientist, between research organisations, between academia and industry or by creating companies.
Biotechnology and genetics research have been the subject of extensive investment by both the public and private sectors, with the resulting products and processes making a significant and increasing contribution to human health and health care.
This document presents the guidelines for entering into research agreements with private companies, which have been adopted by the Danish teaching hospitals.
Human biobanks and genetic research databases which bring together and allow the sharing of human biological material and information derived from its analysis, are a key element of the scientific infrastructure underpinning such research.
The path from understanding a disease to bringing a safe and effective new treatment to patients is lengthy and complex. Scientists work to piece together the basic causes of disease at the level of genes, proteins and cells.
This document starts from the observation that in tandem with rapid advances in biotechnology research having valuable applications for use in healthcare the Canadian technology transfer activity has grown significantly.
The IOCB Technology Transfer Office s.r.o (IOCB TTO) is a wholly-owned subsidiary company of IOCB and a leading technology transfer office in the Czech Republic in the field of pharmaceutical, chemical and biotechnology research and development.
Samples of human biological material are used for many purposes and are of increasing importance as the funders of research, whether public, charitable or commercial, prioritise areas which rely upon access to human biological samples.
Join our newsletter and get the latest news